Article info

Download PDFPDF
Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Authors

  1. Correspondence to Dr Amand Floriaan Schmidt, Institute of Cardiovascular Science, University College London, London WC1E 6BT, UK; amand.schmidt{at}ucl.ac.uk
View Full Text

Citation

Carter J, Hingorani AD, Wilkins J, et al
Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Publication history

  • First published November 23, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.